Month: June 2020

   Atos multiplie par 5 la puissance de calcul du Centre de calcul allemand en climatologie (DKRZ) avec sa technologie BullSequanaParis, le 22 juin 2020 – Atos, leader international de la transformation digitale, annonce la signature d’un contrat d’une durée de 5 ans avec le Centre de calcul allemand en climatologie (DKRZ) pour livrer, d’ici le milieu de l’année 2021, un supercalculateur basé sur la technologie BullSequana XH2000. Ce supercalculateur multipliera par 5 la puissance de calcul dont dispose actuellement DKRZ avec son ordinateur haute-performance Mistral, fourni par Atos en 2015.Les systèmes BullSequana améliorent les prévisions climatiquesÀ l’image d’un puissant télescope qui fournit des images détaillées de l’espace, un puissant supercalculateur permet de réaliser des simulations plus complexes et donc d’en apprendre encore...

Beregningen af indre værdier for samtlige afdelinger i Investeringsforeningen PFA Invest er forsinket som følge af tekniske udfordringer.Indre værdi vil blive beregnet og offentliggjort hurtigst muligt.

Efecte Plc – Managers’ transactions – Schneider____________________________________________Person subject to the notification requirementName: Schneider, PeterPosition: Other senior managerIssuer: Efecte PlcLEI: 7437005U8P0KDN6RKW34Notification type: INITIAL NOTIFICATIONReference number: 7437005U8P0KDN6RKW34_20200618105909_15____________________________________________Transaction date: 2020-06-17Venue not applicableInstrument type: SHAREISIN: FI4000282868Nature of the transaction: SUBSCRIPTION(X) Linked to stock option programmeTransaction details(1): Volume: 6000 Unit price: 1.50 EURAggregated transactions(1): Volume: 6000 Volume weighted average price: 1.50 EUR Further inquiries:Taru MäkinenCFOEfecte Plctaru.makinen@efecte.com+358 40 507 1085Certified Adviser:Evli Bank Plc, tel +358 40 579 6210 Efecte PlcEfecte helps...

Efecte Oyj – Johdon liiketoimet – Schneider____________________________________________IlmoitusvelvollinenNimi: Schneider, PeterAsema: Muu ylin johtoLiikkeeseenlaskija: Efecte OyjLEI: 7437005U8P0KDN6RKW34Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 7437005U8P0KDN6RKW34_20200618105909_15____________________________________________Liiketoimen päivämäärä: 2020-06-17Kauppapaikka ei sovelluInstrumentti tyyppi: OSAKEISIN: FI4000282868Liiketoimen luonne: MERKINTÄ(X) Liiketoimi liittyy osakeoptio-ohjelman toteuttamiseenLiiketoimien yksityiskohtaiset tiedot(1): Volyymi: 6000 Yksikköhinta: 1.50 EURLiiketoimien yhdistetyt tiedot(1): Volyymi: 6000 Keskihinta: 1.50 EUR Lisätietoja:Taru MäkinenTalousjohtajaEfecte Oyjtaru.makinen@efecte.com040 507 1085Hyväksytty neuvonantaja:Evli Pankki Oyj, puh. 040 579 6210 Efecte OyjEfecte auttaa...

22 June 2020Announcement no. 29/2020Rasmus Werner Nielsen appointed CEO of Alm. BrandRasmus Werner Nielsen is appointed CEO of Alm. Brand after having served as interim CEO since autumn 2019.The appointment is made following the Danish Financial Supervisory Authority’s confirmation, that Rasmus Werner Nielsen meets the requirements for fitness and integrity according to section 64 of the Financial Business Act, the so-called “fit & proper” rules.As CEO, Rasmus Werner Nielsen will be heading the process of creating an even stronger Alm. Brand and delivering on the group’s ambitious goals for the benefit of customers, employees and shareholders. Chairman of the Board of Directors of Alm. Brand, Jørgen Hesselbjerg Mikkelsen, said: “In appointing Rasmus Werner Nielsen as CEO, Alm. Brand will get a routined, strategically...

22. juni 2020Selskabsmeddelelse nr. 29/2020Rasmus Werner Nielsen udnævnes til adm. direktør i Alm. BrandRasmus Werner Nielsen udnævnes til adm. direktør i Alm. Brand efter at have været konstitueret direktør siden efteråret 2019.Udnævnelsen sker i forlængelse af Finanstilsynets bekræftelse af, at Rasmus Werner Nielsen opfylder kravene til egnethed og hæderlighed efter § 64 i lov om finansiel virksomhed, de såkaldte ”fit & proper”-regler.Rasmus Werner Nielsen får dermed ansvaret for at lede arbejdet med at skabe et stærkere Alm. Brand og indfri koncernens ambitiøse målsætninger til glæde for kunder, medarbejdere og aktionærer. Bestyrelses-formand i Alm. Brand, Jørgen Hesselbjerg Mikkelsen, siger: ”Med Rasmus Werner Nielsen får Alm. Brand en rutineret, strategisk stærk og handlekraftig topleder. Han har som konstitueret direktør allerede...

HERZLIYA, Israel, June 22, 2020 (GLOBE NEWSWIRE) — Safe-T Group Ltd. (Nasdaq, TASE:SFET), a leading provider of secure access solutions, today announced that it has been identified as a Representative Vendor in the Gartner Market Guide for Zero Trust Network Access (“ZTNA”) report1. Safe-T was named a Representative Vendor of Stand-Alone ZTNA.According to Gartner, “The old security model of “inside means trusted” and “outside means untrusted” is broken. When users became mobile and when business partners on the “outside” required access, virtual private networks (VPNs) and demilitarized zones (DMZs) became common. They also granted excessive implicit trust – trust that attackers abused. The reality of digital business is that it requires anywhere, anytime access to any application, regardless of the locations of the users...

MudraaSoftTrade provides buy sell signal software with auto buy sell signal generation that scans market trend in very early stage and gives trading alert at right time. One could know exactly when to buy, hold or sell stocks or commodities. Complete software training will be provided before anyone starts trading. No technical knowledge is required. MudraaSoftTrade provide clients with multiple formulas that one can easily analyze, learn and apply strategies to generate guaranteed binary income from home. This buy sell software has smart indicators that scans entire market and guide traders about when to BUY or SELL any stock or commodity.With advance smart indicators fake call detection becomes easy & one can actually get sure shot calls while trading to maximize trade profit. Thus, overall accuracy goes beyond 90% One can get extra...

—Phase 2/3 platform trial sponsored by Cambridge University Hospitals NHS Foundation Trust——Experimental therapies with potential to prevent and treat complications of COVID-19——EDP1815 selected as one of two experimental therapies in the trial——EDP1815 has been observed to have favorable tolerability and anti-inflammatory activity in a prior clinical trial——Interim data expected in fourth quarter of 2020—CAMBRIDGE, Mass. and LONDON, June 22, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO) a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologic therapies, announced today that EDP1815 will be included in the TACTIC-E clinical trial. The trial will evaluate the safety and efficacy of certain experimental therapies in the prevention and treatment of life-threatening...

Aspocomp Group Plc, Managers’ Transactions, June 22, 2020 at 8:30 a.m. ____________________________________________ Person subject to the notification requirement Name: Joensuun Kauppa ja Kone Oy Position: Closely associated person (X) Legal person